Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
about
IRF7: activation, regulation, modification and functionViral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activationPolymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosusThe IRF family, revisitedA Novel Unsupervised Method to Identify Genes Important in the Anti-viral Response: Application to Interferon/Ribavirin in Hepatitis C PatientsEstablishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus InfectionA common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosusA type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaAn individualized predictor of health and disease using paired reference and target samples.Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver.Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamicsFunctional analysis of a dominant negative mutation of interferon regulatory factor 5Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsCritical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.Differential gene expression downstream of Toll-like receptors (TLRs): role of c-Src and activating transcription factor 3 (ATF3).Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic virusesSOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.IRF7 regulates TLR2-mediated activation of splenic CD11c(hi) dendritic cells.Genetic associations in type I interferon related pathways with autoimmunityMapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaTranscription factor redundancy ensures induction of the antiviral stateThe ISG56/IFIT1 gene family.IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signalingRNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells.Interferon regulatory factors: critical mediators of human lupus.Interferon-induced Ifit proteins: their role in viral pathogenesisDifferential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani.Genetic polymorphism of interferon regulatory factor 5 (IRF5) correlates with allograft acute rejection of liver transplantation.A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infectionGenetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression.IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania InfectionThree functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons
P2860
Q24299740-F5565CD8-6190-4D72-A079-1DA4A35CCA9AQ24315019-0F09AD6B-749C-4EEE-A129-094BCBA1D377Q24530690-A546966C-1362-4E50-A743-85008F71252AQ24678497-ED8BDE67-AC54-4AF9-8E92-D865836CDB60Q27481065-DB75B304-C071-4A62-9BB7-DB02BAE8C774Q27485316-6E0563E5-C7B4-43E2-9897-A73F965BAB66Q27486785-FE5872F9-B288-4042-A3CA-77C52F8D1ED8Q28236839-0B2DBBBF-039C-490D-BC0E-B3100B1A73DDQ28257957-6A612864-30ED-4930-BD2C-B856680C99DFQ28265144-22E0275D-BB7A-4E7F-BA85-A46D8A044096Q30361306-CFB528CA-A4B3-4493-A1C5-C7F32BD52406Q30499231-F9A3D893-9409-4130-B187-86AD50A2C4A1Q33325887-F10014D6-BF98-4596-B676-25FCF196CE70Q33442833-6E69FA0A-38C7-4CC1-A3A7-C02566310732Q33703923-CFBE481C-CD0C-4E9E-9E11-AB8E4BB4555DQ33799144-84F3C480-DBD0-407E-8DF9-3D75121F9671Q33883292-21B8879C-AB89-4780-87BD-FF24905E758AQ33987481-53D62B32-98B2-42C6-9139-B9082DE15A81Q34110261-8C0AAB0A-5767-46A3-A427-A3FCF74BAE89Q34211024-3FFBA5D5-EAC3-4872-B7CA-87A005B29E0BQ34261880-5FC9B82C-969B-4320-9844-7A2161EA58DAQ34261893-F917BD4F-7A87-4F0A-900E-948393A803B6Q34345575-DD9D7229-B03B-452D-9161-CB348F55AD2CQ34350182-F38CC66A-95B2-49AD-BF01-CF6ADBD60804Q34408939-F63BFEFC-1C00-4790-82CD-E056C87FBE12Q34439072-2F901FF1-36F6-4CAC-93C1-E3A8C70A7F64Q34492459-FF37AB45-384E-4A6A-AB49-6418D7DA3DB4Q34539832-8207A3DF-C449-46AC-BC97-F82D17E34A5BQ34563170-2D96086A-B828-41BA-908C-B3059DCF23FCQ34708883-E8579F35-EE2C-4E0F-B7BC-892767435445Q35014051-A648E94A-B8DA-42A0-8F1A-2075926A7CD8Q35076741-BF333C99-F631-4DB8-8B07-582559D00F4AQ35127522-88C3C207-10C7-4207-8487-7A7B6D100C7FQ35161570-BA226F3E-F806-45DB-B3CB-33CDA5CD5A65Q35347846-03948AAC-022C-4D6F-BFF0-5FC4DEE25C57Q35542816-64CEBD94-56E0-4DC2-9A44-9A5E881CAF71Q35599579-FA83BC28-24D4-42E7-A7B5-3369FA9EE191Q35653927-AF74E8C1-533D-404B-BEB3-749EF9FDA695Q35741943-1076E139-3EE7-4158-8C29-3CE0CE9F272FQ35784689-1ECCDA4B-E387-43CB-84B5-49497B798DFD
P2860
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@ast
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@en
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@nl
type
label
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@ast
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@en
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@nl
prefLabel
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@ast
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@en
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@nl
P2093
P3181
P356
P1476
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
@en
P2093
Betsy J Barnes
John Richards
Laura Beretta
Margo Mancl
Paula M Pitha
Sam Hanash
P304
P3181
P356
10.1074/JBC.M400726200
P407
P577
2004-10-22T00:00:00Z